GP training may ease long COVID burden

NCT ID NCT06082258

Terminated Symptom relief Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This trial tests whether training general practitioners to better manage persistent symptoms after COVID-19 can improve patients' quality of life. Adults with at least two long COVID symptoms (like fatigue, breathlessness, or brain fog) lasting over two months will be enrolled. The study compares standard care to a program where GPs receive specialized training and are reimbursed for longer consultations. The main goal is to see if patients report better physical health after three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: training and support intervention for general practitioners
What this could lead to: If effective, this approach could offer a practical way to improve quality of life for people with persistent post-COVID symptoms through better GP care.
What could go wrong: This is a relatively small, early-stage study focused on GP training rather than a direct treatment, so benefits may be modest or not generalizable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-ACUTE COVID-19 SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

long COVID-19 post-COVID-19 disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST-ACUTE COVID-19 SYNDROME

Contacts and locations

Locations

DAC 75

Paris, 75013, France
DAC 92

Suresnes, 92150, France
DAC 93

Saint-Denis, 93200, France
Paris Est (CPTS 12e et 20e)

Paris, 75012, France
Paris Nord (CPTS 10e)

Paris, 75010, France
Paris Ouest (CPTS 15e)

Paris, 75015, France
Paris Sud (CPTS 13-14e)

Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.